Aarti Kawatkar

Aarti Kawatkar is an Associate Principal Scientist at AstraZeneca since May 2021, managing a target deconvolution portfolio while facilitating communication across various therapeutic areas such as Oncology, CVRM, R&I, and Neuroscience. Aarti has extensive experience within AstraZeneca, holding roles including Senior Scientist in Chemical Biology and Proteomics, where responsibilities encompassed the design and synthesis of small molecules for biological target validation, and in Fragment Based Lead Generation, focusing on medicinal chemistry strategies. Aarti's earlier experience includes work at Vertex Pharmaceuticals designing sodium channel modulators for pain management, and a foundational role as a Research Associate at Clariant, where process safety and scale-up procedures were emphasized. Aarti's education includes advanced studies in Proteomics and Medicinal Chemistry from reputable institutions.